Jeffrey Robert Ajer - Sep 30, 2025 Form 4 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role
Director
Signature
Mark A. Wilson, Attorney-in-Fact
Stock symbol
NKTR
Transactions as of
Sep 30, 2025
Transactions value $
$0
Form type
4
Date filed
10/1/2025, 07:49 PM
Previous filing
Jul 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ajer Jeffrey Robert Director C/O NEKTAR THERAPEUTICS, 455 MISSION BAY BLVD SOUTH, SAN FRANCISCO Mark A. Wilson, Attorney-in-Fact 2025-10-01 0001557533

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTR Stock Option Award $0 +8K $0.00 8K Sep 30, 2025 Common Stock 8K $56.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.